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Abstract- The purpose of the present study was to estimate the frequency of HPV DNA in four groups
of oral lesions, including oral squamous cell carcinoma. Sixty paraffin-embedded oral tissue samples
were examined for the presence of HPV DNAs using the PCR technique. These specimens were 
obtained from patients with oral squamous cell carcinoma (OSCC), leukoplakia, oral lichen planus
(OLP), and pyogenic granuloma (PG). Consensus primers for L1 region (MY09 and MY11) and
specific primers were used for detection of HPV DNA sequences in this study. we detected HPV DNA
in 60% (9 out of 15) of OSCCs, 26.7% (4 out of 15) of leukoplakia, 13.3% (2 out of 15) of OLPs, and
6.7% (1 out of 15) of PGs. Statistical analysis showed that the prevalence of HPV in OSCC was
significantly higher than other groups (P < 0.05). The frequency of HPV-16 and 18 detection in OSCC
samples were 40% and 20%, respectively. The prevalence of these high risk HPVs was significantly
higher in OSCC group (P < 0.05). The results of the present study show a successive increase of
detection rate of HPV-16 and 18 DNAs from low level in samples of pyogenic granuloma and non­
premalignant or questionably premalignant lesions of OLP to premalignant leukoplakia and to OSCC.
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INTRODUCTION 
 
Squamous cell carcinoma is a malignant tumor 
common to the skin, mouth, and other body cavities 
covered by a squamous epithelium. Oral squamous 
cell carcinoma (OSCC) is the sixth most common 
cancer of the body and is one of the 10 most 
common causes of death  worldwide  (1, 2).  Cancers  
Received: 14 Jul. 2006, Revised: 29 Aug. 2006, Accepted: 30 Oct. 2006                 
 
* Corresponding Author:  
Mohammad Reza Zarei, School of Dentistry, Shafa Ave, Kerman 
7618759689, Iran 
Tel: +98 341 2118074-09131966398 
Fax: +98 341 2118073 
E-mail: zarei@icdr.ac.ir 
of the oral cavity and oropharynx account for
approximately 3% of all new cancers diagnosed 
annually in the United States (about 30000 cases per
year) (2). However, the incidence of OSCC varies in 
different geographic locations. OSCC accounts for
up to 40% of all malignancies in India and South 
East Asia (1). There is substantial evidence that
OSCC is usually etiologically linked with tobacco 
and/or alcohol or betel use (2). However, differences
have been observed in tobacco smoking and alcohol
drinking habits in OSCC patients. There are clearly
patients who develop OSCC in the absence of
   
  
  
  
  
  
    
   
 
  
  
   
 
  
 
  
 
  
  
  
    
  
    
 
  
 
    
  
 
  
 
 
 
 
 
   
   
 
 
 
  
   
   
 
 
 
  
  
 
  
  
 
  
  
   
  
 
 
    
  
   
    
  
 
   
   
         
 
   
    
    
    
    
    
Detection of HPV DNA sequence by PCR 
exposure to these agents and in the absence of any
obvious predisposing genetic defect (3). Since 
carcinogenesis is a multi-step process and transition 
from normal mucosa to invasive SCC takes a long 
time, it is possible that several other factors, such as
dietary factors and viruses (especially human 
papillomavirus) play a role in the development of
OSCC. Papillomaviruses are small, non-enveloped, 
icosahedral DNA viruses of about 55 nm in 
diameter. Virus particles contain a circular, double-
stranded, covalently closed DNA of about 8000 base 
pairs in length, which is complexed by cellular
histones and packaged in a protein coat (4). It is
believed that human papillomaviruses (HPV) are 
capable of inducing hyperplastic, papillomatous, and 
verrucous squamous epithelial lesions in the skin and 
at various mucosal sites, including oral cavity (5).  
More than 100 human papillomaviruses have
been identified so far, some of which are 
carcinogenic, while the majority generally cause 
benign epithelial lesions (6). In the oral cavity, 24 
types have been shown to be associated with benign 
lesions and at least 12 types with malignant lesions, 
among them HPV-16 and 18 play especially
important roles in the development of OSCCs (7). 
Although HPVs have been implicated in the OSCC, 
but the field has been controversial. Many groups
have identified HPV in patients with OSCC, but the 
results of case series and case control studies have
not been consistent (3). The aim of the present study
was to determine the presence of HPV-16 and 18 in 
four groups of oral lesions, including OSCC, using 
the PCR technique. 
MATERIALS AND METHODS
Specimens
Sixty formalin-fixed and paraffin-embedded tissue 
samples that had been examined at the Department
of Oral Pathology, School of Dentistry, Kerman 
University of Medical Sciences from 1995 to 2003, 
were used. Microscopic slides of all samples were 
reviewed by a second pathologist to confirm the 
histologic diagnosis. These specimens were obtained 
from patients with oral squamous cell carcinoma 
(OSCC), leukoplakia, oral lichen planus (OLP), or
pyogenic granuloma (PG) (15 specimens in each 
group) and were chosen on a random basis. Table 1 
shows the age and sex distribution of the patients in 
each group. 
Extraction of DNA and PCR amplification
Extraction of DNA and PCR amplification was done 
at Department of Virology, Tehran University of
Medical Sciences.  
DNA was extracted from 5 µM paraffin sections, 
avoiding any cross contamination between samples
(using separate disposable stuffs such as gloves, 
blade and tubes).  
The first section of each specimens plus gloves
and blade were discarded and new blade and gloves
were used for main sectioning. 
Sections were deparaffinized and placed in 200 
µl of digestion buffer (50 mM Tris, PH 8.5, 1 mM
EDTA, 0.5% Tween 20) containing 200 µg/ml
proteinase K and incubated overnight at 37°C (8). 
The lysate was extracted twice with phenol:
chloroform (1:1), and precipitated by ethanol. The 
DNA was dissolved in 100 µl TE buffer. The 
extracted DNA was stored at 4°C until to be tested. 
DNA quality was evaluated in all specimens by PCR
using primers PCO3/PCO4 (PCO3: 5´ ACA CAA
CTG TGT TCA CTA GC /PCO4: 5´ CAA CTT 
CAT CCA CGT TCA CC), that amplifies a 110 base 
pair product from human β-globin gene. HPV
consensus primers, MY09 and MY11 which cover a 
broad spectrum of HPV types, were used in the PCR
assay to amplify an approximately 450 bp fragment
from the open reading frame L1 region (ORF)
(9). 
Table 1. Age and sex distribution of the study population
Group Age Range (Year) Mean Age Sex Male Female 
Oral squamous cell carcinoma 27-74 51 11/15 (73.3%) 4/15 (26.7%)
Leukoplakia 31-67 45.9 12/15 (80%) 3/15 (20%)
Oral lichen planus 25-67 43.2 6/15 (40%) 9/15 (60%)
Pyogenic granuloma 4-65 32.2 7/15 (46.7%) 8/15 (53.3%)
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      Fig. 1. Detection of 450 bp L1 PCR product, on 1.5% agarose gel electrophoresis.
The sequences of the primers are MY09: 5' CGT 
CCM ARR GGA WAC TGA TC 3’ and MY11: 5' 
GCM CAG GGW CAT AAY AAT GG 3'. PCR 
amplification carried out in a DNA thermal cycler 
and involved an initial denaturation, followed by 38 
cycles at 95°C for 60 sec, 55 °C for 60 sec, and 72°C 
for 120 sec with an additional final cycle at 95°C for 
60 sec, 55°C for 60 sec, and 72 °C for 5 min. Each 
PCR experiment was run in parallel with a negative 
control and a DNA sample known to be positive for 
HPV. Extracted DNA from HeLa cell line was used 
as HPV positive control. No DNA was added for 
negative controls. The material of positive HPV 
samples was used for determination of HPV types, 
including HPV-16 and 18 among others, using PCR 
method. Specific primers were used at this stage. 
The sequences of primers used for detection of HPV­
16 and 18 were HPV-16-T7: 5' TTA ATA CGA 
CTC ACT ATA GGG TCA TTT GTT GGG GTA 
ACC AA 3', HPV-16-2: 5' TAG GTC TGC AGA 
AAA CTT TTC 3', HPV-18-T7: 5' TTA ATA CGA 
CTC ACT ATA GGG TTT GTT GGG GCA ATC 
AGG TA 3' and HPV18-2: 5΄ TAA GTC TAA AGA 
AAA CTT TTC 3΄. PCR was done as described above. 
Statistical analysis 
The statistical analysis included X2 and Fisher exact 
tests. P values < 0.05 were considered significant. 
RESULTS 
Sixty oral mucosal specimens with benign or 
malignant epithelial changes were analyzed for HPV 
DNA by the PCR.  
L1 PCR showed that 9 (60%) of the 15 OSCC 
samples were positive for HPV DNA (Fig. 1). HPV 
DNA was identified in 26.7% of leukoplakia, 13.3% 
of OLP, and 6.7% of PG specimens as indicated by a 
450 bp L1 PCR product, on 1.5% agarose gel 
electrophoresis (Tables 2 and 3). The frequency of 
HPV DNA detection in OSCC was significantly 
higher than leukoplakia, OLP, and PG (P < 0.05). 
The results for HPV DNA typing by PCR showed 
that 6 (40%) of the 15 OSCC specimens were 
positive for HPV-16 DNA and 3 (20%) of these 
samples were positive for HPV-18 DNA. HPV-16 
DNA was found with the type specific primers in 
13.3% (2/15) of leukoplakia. Neither HPV-16 DNA 
nor HPV-18 DNA was identified in OLP and PG 
specimens. Statistical analysis showed that the 
frequency of HPV-16 and 18 DNA detection in 
OSCC as compared with leukoplakia, OLP, and PG 
was significantly higher (P < 0.05). There was no 
statistically significant association between HPV 
status and gender, age, or tumor location in OSCC 
cases. 
      Table 2. HPV types in biopsy specimens of four different oral lesions
Group   PCR+
 HPV Types
6 11 16 18 
 OSCC 9/15 (60%)  - -  6 (40%) 3 (20%) 
 Leukoplakia 4/15 (26.7%) - 2 (13.3%) 2 (13.3%) - 
OLP 2/15 (13.3%) 2 (13.3%) - - - 
PG   1/15 (6.7%)  -   1 (6.7%) - -
  Abbreviations: OSCC, oral squamous cell carcinoma; OLP, oral lichen planus; PG, pyogenic granuloma.
 
 
 
Acta Medica Iranica, Vol. 45, No. 3 (2007) 179
   
     Table 3. Clinical data and HPV type in the study population
 
No.   Histologic diagnosis Age Sex  Location Detected HPV

1 
2 
3 
4 
5
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
 OSCC
 OSCC
 OSCC
 OSCC
 OSCC
 OSCC
 OSCC
 OSCC
 OSCC
 OSCC
 OSCC
 OSCC
 OSCC
 OSCC
 OSCC
 Non-dysplastic leukoplakia
 Non-dysplastic leukoplakia
  Mild dysplastic leukoplakia
 Non-dysplastic leukoplakia
Moderate dysplastic leukoplakia 
 Non-dysplastic leukoplakia
 Non-dysplastic leukoplakia
 Non-dysplastic leukoplakia
 Non-dysplastic leukoplakia
 Non-dysplastic leukoplakia
 Non-dysplastic leukoplakia
 Non-dysplastic leukoplakia
 Non-dysplastic leukoplakia
 Non-dysplastic leukoplakia
 Non-dysplastic leukoplakia
 Lichen planus
 Lichen planus
 Lichen planus
 Lichen planus
 Lichen planus
 Lichen planus
 Lichen planus
 Lichen planus
 Lichen planus
 Lichen planus
 Lichen planus
  Lichen planus with dysplasia
 Lichen planus
 Lichen planus
 Lichen planus
 Pyogenic granuloma
 Pyogenic granuloma
 Pyogenic granuloma
 Pyogenic granuloma
 Pyogenic granuloma
 Pyogenic granuloma
 Pyogenic granuloma
 Pyogenic granuloma
 Pyogenic granuloma
 Pyogenic granuloma
 Pyogenic granuloma
 Pyogenic granuloma
 Pyogenic granuloma
 Pyogenic granuloma
 Pyogenic granuloma
27 
58 
68 
65 
40 
55 
73 
31 
35 
46 
53 
52 
37 
52 
74 
67 
31 
49 
48 
31 
57 
44 
48 
39 
50 
35 
54 
50 
43 
43 
30 
50 
39 
36 
28 
39 
48 
38 
67 
49 
37 
60 
43 
25 
60 
17 
19 
15 
64 
50 
65 
35 
47 
32 
9 
15 
50 
4 
53 
9 
M 
M 
M 
M 
M 
F 
M 
M 
M 
M 
F 
F 
M 
F 
M 
F 
M 
M 
M 
M 
M 
M 
M 
F 
M 
F 
M 
M 
M 
M 
M 
F 
M 
M 
M 
F 
F 
M 
F 
F 
F 
F 
F 
M 
F 
F 
F 
M 
M 
F 
F 
M 
F 
F 
F 
M 
M 
M 
F 
M 
 Gingiva
Alveolar ridge 
Hard palate 
 Tongue
Buccal mucosa 
 Gingiva
Lip 
 Gingiva
 Gingiva
Lip 
Alveolar ridge 
Lip 
Buccal mucosa 
Alveolar ridge 
Lip 
Alveolar ridge 
 Gingiva
Buccal mucosa 
Buccal mucosa 
Buccal mucosa 
Buccal mucosa 
Buccal mucosa 
 Gingiva
Buccal mucosa 
 Gingiva
 Gingiva
Buccal mucosa 
 Mouth floor
Buccal mucosa 
Buccal mucosa 
Buccal mucosa 
 Gingiva
Buccal mucosa 
Buccal mucosa 
Buccal mucosa 
Buccal mucosa 
 Gingiva
Buccal mucosa 
Buccal mucosa 
Buccal mucosa 
Buccal mucosa 
Buccal mucosa 
Buccal mucosa 
Buccal mucosa 
Buccal mucosa 
 Gingiva
 Gingiva
Lip 
 Gingiva
 Tongue
 Gingiva
 Gingiva
 Gingiva
 Gingiva
 Gingiva
 Gingiva
 Gingiva
 Gingiva
 Gingiva
 Gingiva
-
16 
16 
-
18 
16 
18 
-
16 
-
16 
-
-
16 
18 
-
-
-
-
-
-
-
-
-
11 
16 
16 
-
-
11 
-
-
-
-
-
-
6 
-
-
-
-
-
6 
-
-
-
-
-
-
-
-
-
-
-
-
-
-
11 
-
-
 Abbreviations: OSCC, oral squamous cell carcinoma; M, male; F, female. 
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DISCUSSION 

Many HPVs are accepted to be involved in 
carcinogenesis. These viruses have been identified in 
various human epithelial neoplasms, including 
malignant and premalignant lesions of uterine 
cervix, vulva, penis, conjunctiva, and upper
aerodigestive tract (10-12). 
Human papillomaviruses have the ability to 
immortalize or transform human fibroblasts and 
keratinocytes in vitro (13). It is believed that HPVs
may promote cellular transformation through 
inactivation of pRb and p53 tumor suppressor
functions and transactivation of a family of
serine/threonine protein kinase cyclin-dependent
kinase (CDK) complexes that control cell division 
(4). HPV DNAs have been detected in OSCC by
numerous investigators (3). However, it is unclear
whether the virus is casually associated with OSCC. 
In the present study, we compared the frequency of
HPV DNA detection in OSCC with three groups of
oral lesions: 1) leukoplakia, the most common oral
premalignant lesion, 2) oral lichen planus, a common 
chronic mucocutaneous disease with a questionable 
or low potential for malignant transformation, and 3)
pyogenic granuloma, a reactive hyperplastic lesion 
that basically originates from the cellular elements of
the connective tissue with a nearly normal epithelial
covering. 
We analyzed 60 oral tissue specimens to detect
HPV DNA by the PCR. Human papillomavirus was
present in 60% of OSCC samples. The prevalence of
HPV DNA in OSCC was significantly higher than 
leukoplakia (26.7%), OLP (13.3%), and PG (6.7%). 
In our study, the frequency of HPV-16 (40%) and 
HPV-18 (20%) infection in OSCC was significantly
higher when compared with leukoplakia, OLP, and 
PG. The percentage of HPV DNA-positive OSCC in 
the present study is consistent with findings of other
investigators who identified HPV DNA in 46.7% to 
66.7% of OSCCs (14-16). However, the rate of HPV
detection in OSCC has varied widely in reports from
0 to 94% (3). The inconsistency in results may be
explained by small sample size in some studies, and 
the presence of HPV DNA below the sensitivity of
the assay. Recently, data from 94 reports (overall
4680 OSCC specimens) were included in meta-
analysis (17). Based on this study, the frequency of
HPV DNA detection in OSCC, benign leukoplakia, 
and normal oral mucosa is 46.5%, 22.2%, and 10%, 
respectively and the difference is statistically
significant. The probability of detecting high-risk 
HPVs in OSCCs was 2.8 times greater than that of
low-risk HPVs in this study.  
The results of the present study show a 
successive increase of detection rate of HPV-16 and 
18 DNAs from low level in pyogenic granuloma and 
non-premalignant or questionably premalignant
lesions of OLP to premalignant leukoplakia and to 
OSCC. This finding is consistent with the results of
a recent study in which HPV DNA has been 
identified in 43.2% of OSCC, 22.2% of leukoplakia, 
and 15.4% of lichen planus cases (18).  
In this study, the prevalence of HPV-16 (40%)
infection in OSSC samples was higher than HPV-18 
(20%). This finding is in agreement with studies by
other investigators (19, 20) and shows that HPV-18 
plays a less significant role in the development of
OSCC. In our study, there was no significant
correlation between presence of HPV DNA and 
sites, gender, or age in the OSCC cases, probably
because of the small number of our cases. Similar
findings have been reported by some investigators
(16, 19). However, Paz et al. in their study on 167 
head and neck SCC found that HPV-associated SCC
had site specificity with the viral DNA frequently
found in tumors in Waldeyer’s tonsillar ring (12). 
Also, a significant association between age and 
presence of HPVs in OSCC has been shown by Cruz 
et al. (21). The prevalence of HPVs in patients older
than 60 years (29.4%) was lower than that in patients
below this age (77.8%).  
In summary, the present study confirms frequent
finding of HPV DNA in OSCC and a significant
association between “high-risk” HPV-16 and 18 and 
OSCC as compared with leukoplakia, oral lichen 
planus, and pyogenic granuloma. 
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